Literature DB >> 7523292

High-resolution mapping of B-cell epitopes within an antigenic sequence from Eimeria tenella.

A Talebi1, G Mulcahy.   

Abstract

Overlapping hexapeptides representing part of an Eimeria tenella antigenic sequence, shown to induce partial immunity to homologous challenge in chickens, were synthesized on polypropylene pins (Pepskan technique; Cambridge Research Biochemicals, Cambridge, United Kingdom). The binding to these hexapeptides of antibodies from chickens infected and rabbits immunized with five species of Eimeria was studied, using the coated pins as the solid phase of an enzyme-linked immunoassay. Antibody binding to most regions of the sequence was demonstrated, with peak areas of antigenicity correlating with the most hydrophilic regions. A particularly hydrophilic and antigenic area towards the N terminus of the sequence consists of a peptide motif repeated five times in the native antigen. Homologous antisera (chicken and rabbit anti-E. tenella antisera) differed in their pattern of reactivity from heterologous sera raised against other Eimeria species. While the former bound to fewer of the hexapeptides than the latter, they did so very strongly, indicating affinity maturation of the antibody response to E. tenella-specific sequences. No antibody reactivity to two regions of the sequence was detected. These regions occur in relatively hydrophilic areas and so are unlikely to be situated in transmembrane domains or in the interior of globular proteins. Synthetic peptides, as used in these experiments, make possible analysis of the fine specificity of immune responses and thus have a role to play in the development of novel vaccines for the control of coccidiosis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7523292      PMCID: PMC303096          DOI: 10.1128/iai.62.10.4202-4207.1994

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  18 in total

1.  Identification of an apically-located antigen that is conserved in sporozoan parasites.

Authors:  D W Taylor; C B Evans; S B Aley; J R Barta; H D Danforth
Journal:  J Protozool       Date:  1990 Nov-Dec

2.  Antibody affinity and valence in viral neutralization.

Authors:  S E Blank; G A Leslie; L W Clem
Journal:  J Immunol       Date:  1972-03       Impact factor: 5.422

3.  Eimeria tenella: accumulation and retention of anticoccidial ionophores by extracellular sporozoites.

Authors:  C K Smith; R G Strout
Journal:  Exp Parasitol       Date:  1979-12       Impact factor: 2.011

4.  Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid.

Authors:  H M Geysen; R H Meloen; S J Barteling
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

5.  Specificity and crossreactivity of immune serum and hybridoma antibodies to various species of avian coccidia.

Authors:  H D Danforth; P C Augustine
Journal:  Poult Sci       Date:  1983-11       Impact factor: 3.352

6.  Characterization of coccidial proteins by two-dimensional sodium dodecyl sulphate-polyacrylamide gel electrophoresis.

Authors:  C A Sutton; M W Shirley; M H Wisher
Journal:  Parasitology       Date:  1989-10       Impact factor: 3.234

7.  Control of chicken coccidiosis.

Authors:  P L Long; T K Jeffers
Journal:  Parasitol Today       Date:  1986-09

8.  Genetically engineered antigen confers partial protection against avian coccidial parasites.

Authors:  H D Danforth; P C Augustine; M D Ruff; R McCandliss; R L Strausberg; M Likel
Journal:  Poult Sci       Date:  1989-12       Impact factor: 3.352

9.  Recombinant interferon-gamma inhibits cell invasion by Eimeria tenella.

Authors:  M H Kogut; C Lange
Journal:  J Interferon Res       Date:  1989-02

10.  Characterization and vaccine potential of a novel recombinant coccidial antigen.

Authors:  G A Miller; B S Bhogal; R McCandliss; R L Strausberg; E J Jessee; A C Anderson; C K Fuchs; J Nagle; M H Likel; J M Strasser
Journal:  Infect Immun       Date:  1989-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.